Health technology assessment: interferon alpha (pegylated and non-pegylated) and ribavirin in the treatment of chronic hepatitis C
|
Health technology assessment: interferon alpha (pegylated and non-pegylated) and ribavirin in the treatment of chronic hepatitis C
11 August 2003 (862.86 Kb 4 mins 11 sec) |
